Key terms

About NOTV

Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. It operates under the Discovery and Safety Assessment (DSA) and Research Models and Services (RMS) segments. The DSA segment focuses on drug discovery and development services. The RMS segment includes commercial production and selling research models, diets, bedding, and bioproducts. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest NOTV news

Apr 08 9:01am ET Analysts Offer Insights on Healthcare Companies: Natera (NTRA) and Inotiv (NOTV) Apr 04 9:39am ET Inotiv trading resumes Apr 04 9:34am ET Inotiv trading halted, volatility trading pause Mar 26 8:50am ET Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Inotiv (NOTV) and Vericel (VCEL) Mar 25 10:25am ET Craig-Hallum Keeps Their Buy Rating on Inotiv (NOTV) Mar 19 5:42pm ET Inotiv Shareholders Elect Board Members, Ratify Auditor for 2024 Mar 01 9:01am ET Analysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL), BioLife Solutions (BLFS) and Inotiv (NOTV) Feb 28 1:50pm ET Inotiv participates in a conference call with Lake Street Feb 28 4:55am ET Inotiv participates in a conference call with Lake Street Feb 26 12:17pm ET Inotiv participates in a conference call with Lake Street Feb 09 4:58am ET Inotiv upgraded to Buy from Hold at Jefferies Feb 08 8:40am ET Craig-Hallum remains bullish on Inotiv following solid start to new year Feb 07 4:18pm ET Inotiv sees FY24 revenue $$580M-$590M, consensus $578.14M Feb 07 4:16pm ET Inotiv reports Q1 EPS (60c), consensus (85c) Feb 05 9:10am ET Analysts’ Top Healthcare Picks: Sensus Healthcare (SRTS), Inotiv (NOTV) Feb 05 8:56am ET Lake Street Sticks to Their Buy Rating for Inotiv (NOTV) Jan 31 8:08am ET PetVivo announces release of clinical study results on Spryng

No recent news articles are available for NOTV

No recent press releases are available for NOTV

NOTV Financials

1-year income & revenue

Key terms

NOTV Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

NOTV Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms